EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methodological Insights Into T‐Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation

Nekruz Abdulhaqov, Lady Tatiana Albarracin Melo, Ines Meinert, Stephan Fricke, Luca Simeoni

European Journal of Immunology · 2026-06 · 56 (6)

DOI: 10.1002/eji.70227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 17.06.2026. Verfasst von Nekruz Abdulhaqov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Institute for Clinical Immunology and Cell Therapeutics, Otto-von-Guericke University, Magdeburg, Germany. Hauptthemen laut MEDLINE: Lymphocyte Activation, CD3 Complex, Ionomycin, CD28 Antigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocyte ActivationCD3 ComplexIonomycinCD28 AntigensT-LymphocytesTetradecanoylphorbol AcetateHumansInterleukin-2Signal TransductionInterleukin-2 Receptor alpha SubunitSTAT5 Transcription FactorCell ProliferationExtracellular Signal-Regulated MAP KinasesCells, Cultured

Substanzen

CD3 ComplexIonomycinCD28 AntigensTetradecanoylphorbol AcetateInterleukin-2Interleukin-2 Receptor alpha SubunitSTAT5 Transcription FactorExtracellular Signal-Regulated MAP Kinases

Autor:innen und Institutionen

  • Medical Faculty, Institute for Clinical Immunology and Cell Therapeutics, Otto-von-Guericke University, Magdeburg, Germany.
  • Republican Oncology Research Center, I. Somoni Avenue, Dushanbe, Tajikistan.
  • Health Campus Immunology, Infectiology and Inflammation (GC-I3), University Hospital, Otto-von-Guericke University, Magdeburg, Germany.
  • Center for Health and Medical Prevention (CHaMP), University Hospital, Otto-von-Guericke University, Magdeburg, Germany.
  • Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)
  • European Regional Development Fund

Zitieren

APA

Abdulhaqov, N., Melo, L. T. A., Meinert, I., Fricke, S., & Simeoni, L. (2026). Methodological Insights Into T‐Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation. European Journal of Immunology, 56(6). https://doi.org/10.1002/eji.70227

Vancouver

Abdulhaqov N, Melo LTA, Meinert I, Fricke S, Simeoni L. Methodological Insights Into T‐Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation. European Journal of Immunology. 2026;56(6). doi:10.1002/eji.70227

BibTeX
@article{Abdulhaqov2026,
  author = {Abdulhaqov, Nekruz and Melo, Lady Tatiana Albarracin and Meinert, Ines and Fricke, Stephan and Simeoni, Luca},
  title = {Methodological Insights Into T‐Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {6},
  doi = {10.1002/eji.70227}
}
Kostenlos starten →